InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Kalkofen Donald A., 首席财务官. Insider active across 1 company, notably Protagonist Therapeutics, Inc. In total, 1 reports have been recorded. History available since 15 February 2022. The latest transaction was disclosed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Donald A. Kalkofen is Chief Financial Officer at Protagonist Therapeutics, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations.